NDC 54092-191 – Pentasa

Mesalamine 500 mg/1 · Capsule · Oral

Human Prescription Drug 1 recall

Product NDC54092-191

Product details

Brand name
Pentasa
Generic name
Mesalamine
Labeler
Takeda Pharmaceuticals America, Inc.
Dosage form
Capsule
Route
Oral
Marketing category
NDA · NDA020049
Marketed since
July 8, 2004
Listing expires
December 31, 2026
Pharmacologic class
Aminosalicylate

Active ingredients

Uses, dosage, side effects and warnings for Pentasa →

Package NDC codes (1)

Package NDCDescriptionSince
54092-191-12120 CAPSULE in 1 BOTTLE (54092-191-12)Jul 8, 2004

Recalls mentioning this NDC

Other Pentasa products